Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 7005-7011

  Hazuda, Daria J ^a   Felock, Peter J ^a   Hastings, Jeffrey C ^a   Pramanik, Bernali ^a   Wolfe, Abigail L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COBALT; DIVALENT CATION; ENZYME INHIBITOR; EXODEOXYRIBONUCLEASE III; INTEGRASE; MANGANESE;

ARTICLE; CATALYSIS; DNA TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; VIRUS DNA CELL DNA INTERACTION;

EID: 0030812190     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.7005-7011.1997     Document Type: Article

References (41)

1. Billich, A., M. Schauer, S. Frank, B. Rosenwirth, and S. Billich. 1992. HIV-1 integrase: high-level production and screening assay for the endonucleolytic activity. Antiviral Chem. Chemother. 3:113-119.
2. Brown, P. O.1990. Integration of retroviral DNA. Curr.Top. Microbiol. Immuol. 157:19-48.
3. Bukrinsky, M. I., N. Sharova, T. L. McDonald, T. Pushkarskaya, W. G. Tarpley, and M. Stevenson. 1993. Association of integrase. matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90:6125-6129.
4. Bushman, F. D., and R. Craigie. 1991. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA 88:1339-1343.
5. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1993. Inhibitory effect of the polyanionic drug Suramin on the in vitro HIV DNA integration reaction. Arch. Biochem. Biophys. 305:606-610.
6. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1993. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration. Arch. Biochem. Biophys. 300:756-760.
7. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1993. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction, Biochem, Biophys. Res. Commun. 192:1409-1414.
8. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1994. Inhibition of the in vitro integration of Moloney murine leukemia virus DNA by the DNA minor groove binder netropsin. Biochem. Pharmacol. 47:1821-1826.
9. Cushman, M., and P. Sherman. 1992. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem. Biophys. Res. Commun. 185:85-90.
10. Cushman, M., W. M. Golebiewski, Y. Pommier, A. Mazumder, D. Reymen, E. De Clercq, L. Graham, and W. G. Rice. 1995. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. J. Med. Chem. 38:443-452.
11. Ellison, V., and P. O. Brown. 1994. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc. Natl. Acad. Sci. USA 91:7316-7320.
12. Engelman, A., and R. Craigie. 1995. Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J. Virol. 69:5908-5911.
13. Farnet, C. M., and W. A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-1915.
14. Farnet, C. M., B. Wang, J. R. Lipford, and F. D. Bushman. 1996. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc. Natl. Acad. Sci. USA 93:9743-9747.
15. Fesen, M. R., K. W. Kohn, F. Leteurtre, and Y. Pommier. 1993. Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. USA 90:2399-2403.
16. Fesen, M. R., Y. Pommier, F. Leteurtre, S. Hiroguchi, J. Yung, and K. W. Kohn. 1994. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48:595-608.
17. Goff, S. P. 1992. Genetics of retroviral integration. Annu. Rev. Genet. 26: 527-544.
18. Grandgenett, D. P., A. C. Vora, and R. D. Schiff. 1978. A 32,000-dalton nucleíc acíd-bíndíng proteín from avian retrovirus cores possesses DNA endonuclease activity. Vìrology 89:119-132.
19. Hazuda, D., P. Felock, J. Hastings, B. Pramanik, A. Wolfe, G. Goodarzi, A. Vora, K. Brackmann, and D. Grandgenett. 1997. Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds. J. Virol. 71:807-811.
20. Hazuda, D. J., J. C. Hastings, A. L. Wolfe, and E. A. Emini. 1994. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acids Res. 22:1121-1122.
21. 20a.Hazuda, D., and A. L. Wolfe. Unpublished data.
22. Karageorgos, L., P. Li, and C. Burrell. 1993. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res. Hum. Retroviruses 9:817-823.
23. LaFemina, R. L., C. L. Schneider, H. L. Robbins, P. L. Callahan, K. LeGrow, E. Roth, W. A. Schleif, and E. A. Emini. 1992. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J. Virol. 66:7414-7419.
24. LaFemina, R. L., P. L. Graham, K. LeGrow, J. C. Hastings, A. Wolfe, S. D. Young, E. A. Emini, and D. J. Hazuda. 1995. Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. 39:320-324.
25. Lee, S. P., H. G. Kim, M. L. Censullo, and M. K. Han. 1995. Characterization of Mg2 + -dependent 3′-processing activity for human immunodeficiency virus type 1 integrase in vitro: real-time kinetic studies using fluorescence resonance energy transfer. Biochemistry 34:10205-10214.
26. Lipford, J. R., S. T. Worland, and C. M. Farnet. 1994. Nucleotide binding by the HIV-1 integrase protein in vitro. J. Acquìred Immun. Defic. Syndr. 7:1215-1223.
27. Mazumder, A., D. Cooney, R. Agbaria, M. Gupta, and Y. Pommier. 1994. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′deoxythymidylate. Proc. Natl. Acad. Sci. USA 91:5771-5775.
28. Mazumder, A., K. Raghavan, J. Weinstein, K. W. Kohn, and Y. Pommier. 1995. Inhibition of human-immunodeficiency-virus type-1 integrase by curcumin. Biochem. Pharmacol. 49:1165-1170.
29. Mazumder, A., A. Gazit, A. Levitzki, M. Nicklaus, J. Yung, G. Kohlhagen, and Y. Pommier. 1995. Effects of tyrophostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase. Biochemistry 34:15111-15122.
30. Mazumder, A., M. Gupta, D. M. Perrin, D. S. Sigman, M. Rabinovitz, M., and Y. Pommier. 1995. Inhibition of human immunodeficiency virus type 1 integrase by the phenanthroline-cuprous complex. AIDS Res. Hum. Retroviruses 11:115-125.
31. Mizuuchi, M., T. A. Baker, and K. Mizuuchi. 1992. Assembly of the active form of the transposase-Mu DNA complex: a critical control point in Mu transposition. Cell 70:303-311.
32. Pemberton, I. K., M. Buckle, and H. Buc. 1996. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II). J. Biol. Chem. 271:1498-1506.
33. Raghavan, K., J. K. Buolamwini, M. R. Fesen, Y. Pommier, K. W. Kohn, and J. N. Weinstein. 1995. Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study. J. Med. Chem. 38:890-897.
34. Rice, P., R. Craigie, and D. R. Davies. 1995. Retroviral integrases and their cousins. Curr. Opin. Struct. Biol. 6:76-83.
35. Sherman, P. A., and J. A. Fyfe. 1990. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc. Natl. Acad. Sci. USA 87:5119-5123.
36. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
37. Varmus, H., and P. Brown. 1989. Retroviruses, p. 53-108. In D. E. Berg and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C.
38. Vincent, K. A., V. Ellison, S. A. Chow, and P. O. Brown. 1993. Characterzation of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J. Virol. 67:425-437.
39. Vink, C., R. A. P. Lutzke, and R. H. A. Plasterk. 1994. Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA. Nucleic Acids Res. 22:4103-4110.
40. Wolfe, A. L., P. J. Felock, J. C. Hastings, C. U. Blau, and D. J. Hazuda. 1996. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates. J. Virol. 70:1424-1432.
41. Zack, J. A., S. J. Arrigo, S. R. Weltsman, A. S. Go, A. Halslip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.